This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Incyte Corporation. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Sherry Owens: Innovator in Biomarker Research
Introduction
Sherry Owens is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of biomarker research, particularly in relation to vitiligo and graft-versus-host disease. With a total of 4 patents to her name, her work is paving the way for advancements in treatment modalities.
Latest Patents
Owens' latest patents include innovative biomarkers for vitiligo. These biomarkers are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The compositions and methods described in her patent are instrumental in selecting appropriate treatment options for individuals with, suspected of having, or at risk of developing vitiligo. Additionally, she has developed biomarkers for graft-versus-host disease, which similarly predict a subject's responsiveness to a JAK inhibitor. This research is crucial for determining effective treatment strategies for those affected by this condition.
Career Highlights
Sherry Owens is currently employed at Incyte Corporation, where she continues to advance her research in biomarker development. Her work has garnered attention in the medical community, highlighting her expertise and dedication to improving patient outcomes.
Collaborations
Owens collaborates with notable colleagues, including Michael D Howell and Michael A Pratta. These partnerships enhance her research efforts and contribute to the innovative solutions being developed at Incyte Corporation.
Conclusion
Sherry Owens is a trailblazer in the field of biomarker research, with a focus on vitiligo and graft-versus-host disease. Her contributions are vital for the future of treatment options in these areas.